| Literature DB >> 2579003 |
S Srikanta, A Rabizadeh, M A Omar, G S Eisenbarth.
Abstract
Assays for islet cell antibodies (ICA) are finding increasing application in clinical diabetology. We have developed a new islet cell antibody assay system (ICA-pA), whose salient features include: (1) utilization of fluorescein-conjugated staphylococcal protein A as a standard second-step reagent, the advantages of this approach being improved "signal" (islet)/"noise" (acini) ratio due to reduction of interfering background acinar pancreatic staining, and facilitation of assay standardization provided by the use of a chemically pure conjugated protein A reagent; (2) monoclonal antibody counterstaining with rhodamine-conjugated BISL-32 for the rapid identification of islets in pancreatic sections; and (3) quantitation of circulating serum ICA by microimmunofluorometric techniques.Entities:
Mesh:
Substances:
Year: 1985 PMID: 2579003 DOI: 10.2337/diab.34.3.300
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461